Solving COVID: April 7, 2021
Vaccines for all adults, travel restrictions ease, and more
- 1. Where things stand
- 2. Biden moves up deadline for making all adults eligible for COVID-19 vaccination
- 3. Fully vaccinated people can travel safely within U.S., CDC says
- 4. Pfizer says its COVID-19 vaccine is still highly effective after 6 months
- 5. Johnson & Johnson will take control of plant that spoiled vaccine doses
1. Where things stand
America's vaccination program continues to make strong headway against the coronavirus pandemic. The U.S. is averaging more than 3 million vaccinations per day, and hit a new record of 4 million daily shots over the weekend. Crucially, the CDC says nearly 80 percent of teachers have received at least one vaccine dose. Nearly 1 in 4 adults are fully vaccinated. The seven-day average of daily deaths is now the lowest since late October. "We're headed in the right direction," said Andy Slavitt, White House senior adviser for COVID-19. However, new daily cases hover stubbornly around 60,000, and nearly half of all new cases in the country are clustered in just five states — New York, Michigan, Florida, Pennsylvania, and New Jersey — according to Johns Hopkins University. Michigan alone is seeing some 6,000 new cases a day, "more than double what it was two weeks earlier," AP reports. The larger trend is worrying: Global cases have risen for six consecutive weeks.
2. Biden moves up deadline for making all adults eligible for COVID-19 vaccination
The White House announced Tuesday that President Biden is moving up the deadline for states to open COVID-19 vaccine eligibility to all adults to April 19, earlier than his previous deadline of May 1. The president credited governors' efforts to meet his original May 1 deadline, which he announced in March. Since then, all 50 states have either made COVID-19 vaccines available to all adults or announced when they will. Hawaii and Oregon are the only states that will face pressure to alter their timetable after Biden's announcement, as they were scheduled to open vaccine eligibility to all adults by May 1. Biden also announced that 150 million COVID-19 vaccine doses have been administered in his first 75 days in office. Despite the progress, Biden said "we still have a lot of work to do. We're still in a life and death race against this virus."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
3. Fully vaccinated people can travel safely within U.S., CDC says
The Centers for Disease Control and Prevention on Friday gave people who are fully vaccinated against COVID-19 the green light to travel within the U.S. without getting tested or self-quarantining. They should, however, still wear a mask in public areas, avoid crowds, and practice good personal hygiene. The rules for those who are partially vaccinated or not vaccinated have not changed. The new guidelines are based on studies of "real-world'' effectiveness of COVID-19 vaccines, said CDC Director Rochelle Walensky.
4. Pfizer says its COVID-19 vaccine is still highly effective after 6 months
Pfizer and BioNTech last week said an analysis of a phase 3 study showed their COVID-19 vaccine was 91.3 percent effective "measured seven days through up to six months after the second dose." It was also 100 percent effective against severe disease as defined by the CDC, as well as 95.3 percent effective against severe disease as defined by the FDA, the companies said. There were no serious safety concerns. Additionally, Pfizer and BioNTech said the vaccine was 100 percent effective in South Africa, where a concerning variant has been spreading. "These data also provide the first clinical results that a vaccine can effectively protect against currently circulating variants, a critical factor to reach herd immunity and end this pandemic for the global population," BioNTech CEO Ugur Sahin said.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
5. Johnson & Johnson will take control of plant that spoiled vaccine doses
At the direction of the Department of Health and Human Services, Johnson & Johnson will take charge of the Baltimore contract plant that ruined 15 million doses of its COVID-19 vaccine, senior federal health officials told The New York Times. The doses were spoiled because of a mistake at the facility run by Emergent BioSolution, a manufacturing partner to both Johnson & Johnson and AstraZeneca. Workers at the plant accidentally mixed up the ingredients of the two shots, delaying future shipments of the Johnson & Johnson vaccine. The error was caught and none of the contaminated drugs made it out of the plant, but the Biden administration isn't taking any chances. Production of the AstraZeneca vaccine will move to an alternative site.
The Washington Post The New York Times
Create an account with the same email registered to your subscription to unlock access.
-
Today's political cartoons - April 24, 2024
Cartoons Wednesday's cartoons - war on the big screen, politicians on the stock market, and more
By The Week US Published
-
Andrew Fahie: the ex-BVI premier, cocaine-filled boats and drug trafficking plot
Under the radar Fahie's defense attorney claimed the British overseas territory leader was 'acting like the fictitious CIA agent Jason Bourne'
By Harriet Marsden, The Week UK Published
-
Ottawa climate talks: can global plastic problem be solved?
In the spotlight Nations aim to draft world's first treaty on plastic pollution, but resistance from oil- and gas-producing countries could limit scope
By Harriet Marsden, The Week UK Published
-
Nigeria's worsening rate of maternal mortality
Under the radar Economic crisis is making hospitals unaffordable, with women increasingly not receiving the care they need
By Harriet Marsden, The Week UK Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
How happy is Finland really?
Today's Big Question Nordic nation tops global happiness survey for seventh year in a row with 'focus on contentment over joy'
By Harriet Marsden, The Week UK Published
-
How Tehran became the world's nose job capital
Under the radar Iranian doctors raise alarm over low costs, weak regulation and online influence of 'Western beauty standards'
By Harriet Marsden, The Week UK Published
-
Africa's renewed battle against female genital mutilation
Under the radar Campaigners call for ban in Sierra Leone after deaths of three girls as coast-to-coast convoy prepares to depart
By Harriet Marsden, The Week UK Published
-
Argentina: the therapy capital of the world
Under the radar Buenos Aires natives go hungry to pay for psychoanalysis, amid growing instability, anxiety – and societal acceptance
By Harriet Marsden, The Week UK Published
-
Does declining birth rate spell doom for Britain?
Today's Big Question Ageing population puts pressure on welfare state, economy and fabric of society, while fertility is rising on populist agendas
By Harriet Marsden, The Week UK Published
-
How a new blood test could revolutionise sepsis diagnosis
The Explainer Early results from ongoing trial suggest faster identification of deadly condition is possible
By The Week Staff Published